Skip to main content
Clinical Trials/DRKS00009391
DRKS00009391
Completed
未知

Pilot study for the evaluation, development and implementation of a breath test to diagnose oral candidiasis

Charité Campus Charité Mitte0 sites20 target enrollmentJanuary 8, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
B37.0
Sponsor
Charité Campus Charité Mitte
Enrollment
20
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 8, 2016
End Date
January 7, 2016
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Charité Campus Charité Mitte

Eligibility Criteria

Inclusion Criteria

  • Ability (verbal, physically and mentally) to understand the nature of the study and to participate
  • \- Willingness to study participation
  • \- Completed and signed informed consent
  • \- Age between 18 and 95 years
  • \- Non\-Smokers (for \= 5 years)
  • \- endentulous participants wearing complete dentures (incl. implant\-assisted prostheses without signs of periimplant infections)
  • Specific inclusion criteria
  • Test group (n\=10\)
  • \- confirmation of diagnosis assumed from clinical signs of candida infection
  • \- patients prior to antifungal therapy according to microbiological results

Exclusion Criteria

  • \- Previous malignancies (\=5 years)
  • \- Severe internal comorbidities (myocardial infarction, cardiomyopathy, NYHA functional class III / IV, severe COPD, renal failure, Diabetes mellitus with HbA1c \=7\.0%, ASA class \=3\)
  • \- Drug addiction, incl. Alcohol
  • \- smokers, ex\-smokers \< 5 years
  • \- Patients under 18 years old
  • \- Patients over 70 years
  • \- Participation in a similar study

Outcomes

Primary Outcomes

Not specified

Similar Trials